Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway

9 Aug 2018

Abstract excerpt

BACKGROUND: Feifukang (FFK) is a traditional Chinese medicine composed of herbs that protect lung function. However, difficulty arises regarding the clinical application of FFK due to the complex mechanism of Chinese medicines. This study aimed to investigate the efficacy of FFK and explore its targeted genes and pathways. METHODS: Histopathological changes and collagen deposition were measured to evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Lung Cancer Treatments and Mutations
Share to Pulmonary Hypertension Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30092799
DOI: 10.1186/s12906-018-2297-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathwayPMID 30092799Read ↗

Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

YuPingFeng (YPF) upregulates caveolin-1 (CAV1) to alleviate pulmonary fibrosis through the TGF-β1/Smad2 pathwaySemantic proximity Read ↗

RNA-seq analysis and in vivo experiments identified the protective effect of kaempferol on idiopathic pulmonary fibrosis by regulating the PPARG/TNC signaling pathway to reduce ECM depositionSemantic proximity Read ↗

Network pharmacology-based mechanistic investigation of Jinshui Huanxian formula acing on idiopathic pulmonary fibrosisSemantic proximity Read ↗

Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosisSemantic proximity Read ↗

Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescenceSemantic proximity Read ↗

Qilongtian Ameliorate Bleomycin-induced Pulmonary Fibrosis in Mice via Inhibiting IL-17 signal pathwaySemantic proximity Read ↗

Nifuroxazide Ameliorates Pulmonary Fibrosis By Blocking Myofibroblast Genesis And Stat3 Activation: A Drug Repurposing StudySemantic proximity Read ↗

Baricitinib improves the efficacy of nintedanib for the treatment of idiopathic pulmonary fibrosisSemantic proximity Read ↗

Therapeutic Role and Potential Mechanism of Astragalus Membranaceus (Huangqi) and Radix Paeoniae Rubra (Chishao) in Idiopathic Pulmonary Fibrosis – Network Pharmacology and Experimental ValidationSemantic proximity Read ↗

Exploration of the Mechanism of Shengxian Decoction Against Chronic Obstructive Pulmonary Disease Based on Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology StrategySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.